Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Rigen Biotech
company
About
Rigen Biotech focuses on the molecular diagnosis of thyroid tumors.
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Rigen Biotech has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Apr 14, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 14, 2022 | Series Unknown | ¥100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Rigen Biotech is funded by 1 investors.
Yinshengtai Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
